COVID-19 Evidence Accelerator: A parallel analysis to describe the use of Hydroxychloroquine with or without Azithromycin among hospitalized COVID-19 patients

BACKGROUND: The COVID-19 pandemic remains a significant global threat. However, despite urgent need, there remains uncertainty surrounding best practices for pharmaceutical interventions to treat COVID-19. In particular, conflicting evidence has emerged surrounding the use of hydroxychloroquine and...

Descripción completa

Detalles Bibliográficos
Autores principales: Stewart, Mark, Rodriguez-Watson, Carla, Albayrak, Adem, Asubonteng, Julius, Belli, Andrew, Brown, Thomas, Cho, Kelly, Das, Ritankar, Eldridge, Elizabeth, Gatto, Nicolle, Gelman, Alice, Gerlovin, Hanna, Goldberg, Stuart L., Hansen, Eric, Hirsch, Jonathan, Ho, Yuk-Lam, Ip, Andrew, Izano, Monika, Jones, Jason, Justice, Amy C., Klesh, Reyna, Kuranz, Seth, Lam, Carson, Mao, Qingqing, Mataraso, Samson, Mera, Robertino, Posner, Daniel C., Rassen, Jeremy A., Siefkas, Anna, Schrag, Andrew, Tourassi, Georgia, Weckstein, Andrew, Wolf, Frank, Bhat, Amar, Winckler, Susan, Sigal, Ellen V., Allen, Jeff
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7968637/
https://www.ncbi.nlm.nih.gov/pubmed/33730088
http://dx.doi.org/10.1371/journal.pone.0248128

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7968637/
https://www.ncbi.nlm.nih.gov/pubmed/33730088
http://dx.doi.org/10.1371/journal.pone.0248128

Ejemplares similares